Maria Bjerke

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts.

Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts.

Journal: European journal of neurology

Published: September 25, 2025

Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy pathology.

Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy pathology.

Journal: Neurobiology of aging

Published: June 17, 2025

Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophy.

Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophy.

Journal: Frontiers in neurology

Published: May 29, 2025

Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.

Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 10, 2025

Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.

Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data.

Journal: Alzheimer's research & therapy

Published: November 18, 2024

Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study.

Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study.

Journal: Alzheimer's research & therapy

Published: April 02, 2024

A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.

A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.

Journal: Frontiers in immunology

Published: December 28, 2023

Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.

Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.

Journal: Journal of Alzheimer's disease : JAD

Published: November 19, 2023

Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method.

Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method.

Journal: Alzheimer's research & therapy

Published: September 13, 2023

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.

Journal: Alzheimer's research & therapy

Published: August 11, 2023

Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.

Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.

Journal: Neuroradiology

Published: July 18, 2023

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic review.

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic review.

Journal: Frontiers in immunology

Published: February 09, 2023

Showing 1-12 of 88

Last Updated: 09/26/2026